Evidence-Based Medicine Guidelines
Haloperidol versus placebo for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Versus Placebo for Schizophrenia." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454758/all/Haloperidol_versus_placebo_for_schizophrenia.
Haloperidol versus placebo for schizophrenia. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454758/all/Haloperidol_versus_placebo_for_schizophrenia. Accessed March 12, 2025.
Haloperidol versus placebo for schizophrenia. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454758/all/Haloperidol_versus_placebo_for_schizophrenia
Haloperidol Versus Placebo for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454758/all/Haloperidol_versus_placebo_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol versus placebo for schizophrenia
ID - 454758
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454758/all/Haloperidol_versus_placebo_for_schizophrenia
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
